Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study

Madhani, A., Sabogal, N., Massillon, D., Paul, L. D., Rodriguez, C., Fine, D., Helmke, S., Winburn, M., Kurian, D., Raiszadeh, F., Teruya, S., Cohn, E., Einstein, A. J., Miller, E. J., Connors, L. H., Maurer, M. S., & Ruberg, F. L. (2023). Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association, 12(15). https://doi.org/10.1161/jaha.122.028973
Authors:
Avni Madhani
Natalia Sabogal
Daniel Massillon
Ludwine D Paul
Carlos Rodriguez
Denise Fine
Stephen Helmke
Morgan Winburn
Damian Kurian
Farbod Raiszadeh
Sergio Teruya
Elizabeth Cohn
Andrew J Einstein
Edward J Miller
Lawreen H Connors
Mathew S Maurer
Frederick L Ruberg
Affiliated Authors:
Carlos Rodriguez
Stephen Helmke
Sergio Teruya
Andrew J Einstein
Mathew S Maurer
Columbia Affiliation:
Subjects:
Amyloid Neuropathies, Familial (MeSH)
Amyloidosis (MeSH)
Cardiomyopathies (MeSH)
Heart Failure (MeSH)
Author Keywords:
amyloid
biomarkers
cardiomyopathy
genetics
heart failure
elink
Publication Type:
Article
Unique ID:
10.1161/jaha.122.028973
PMID:
37486082
DOI:
10.1161/jaha.122.028973
Journal:
Journal of the American Heart Association
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: